Open Access
| Issue |
BIO Web Conf.
Volume 135, 2024
4th International Conference on Pharmaceutical Updates (ICPU 2024)
|
|
|---|---|---|
| Article Number | 02005 | |
| Number of page(s) | 7 | |
| Section | Treatment Evaluation Updates | |
| DOI | https://doi.org/10.1051/bioconf/202413502005 | |
| Published online | 07 November 2024 | |
- Badan Penelitian dan Pengembangan Kesehatan KKR. Riset Kesehatan Dasar 2018.pdf. 2018. [Google Scholar]
- Zuberi A, Waqas A, Naveed S, Hossain MM, Rahman A, Saeed K, et al. Prevalence of Mental Disorders in the WHO Eastern Mediterranean Region: A Systematic Review and MetaAnalysis. Front Psychiatry. 2021;12:665019. [CrossRef] [PubMed] [Google Scholar]
- Steel Z, Marnane C, Iranpour C, Chey T, Jackson JW, Patel V, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014 Apr;43(2):476–93. [CrossRef] [PubMed] [Google Scholar]
- Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: A metaanalysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015 Mar;56(3):345–65. [CrossRef] [Google Scholar]
- Orzechowska A, Filip M, Gałecki P. Influence of Pharmacotherapy on Cognitive Functions in Depression: A Review of the Literature. Med Sci Monit Int Med J Exp Clin Res. 2015 Nov 24;21:3643–51. [Google Scholar]
- Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-Møller K, et al. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry. 2017 Feb 8;17(1):58. [Google Scholar]
- Pae CU. Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not? Chonnam Med J. 2020;56(3):157. [CrossRef] [PubMed] [Google Scholar]
- Zhang L, He S, He L, Yu W, He S, Li Y, et al. Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up “Real World” Study in China. Front Pharmacol [Internet]. 2022 [cited 2023 Oct 7];13. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2022.860713 [Google Scholar]
- Abousheishaa AA, Sulaiman AH, Huri HZ, Kamis SFB, Hamidi H, Ang WC, et al. Psychiatric pharmaceutical care service across Malaysian hospitals: results from a crosssectional study. BMC Health Serv Res. 2022 Mar 9;22:321. [CrossRef] [PubMed] [Google Scholar]
- Murphy AL, Phelan H, Haslam S, MartinMisener R, Kutcher SP, Gardner DM. Community pharmacists’ experiences in mental illness and addictions care: a qualitative study. Subst Abuse Treat Prev Policy. 2016 Jan 28;11:6. [CrossRef] [PubMed] [Google Scholar]
- Lincoln Y, Guba E. Naturalistic Inquiry. CA Sage Publ [Internet]. 1985 [cited 2023 Dec 26]; Available from: http://www.qualres.org/HomeLinc-3684.html [Google Scholar]
- Aljumah K, Hassali M. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC Psychiatry. 2015 Sep 16;15:219. [CrossRef] [PubMed] [Google Scholar]
- De Las Cuevas C. Psychiatric Patients’ Perceived Health Control and Reactance: Implications for Medication Adherence. Patient Prefer Adherence. 2023;17:1591–601. [CrossRef] [Google Scholar]
- Kamusheva M, Ignatova D, Golda A, Skowron A. The Potential Role of the Pharmacist in Supporting Patients with Depression – A Literature-Based Point of View. Integr Pharm Res Pract. 2020 Feb;Volume 9:49–63. [PubMed] [Google Scholar]
- Chawla S, Kumar S. Adverse Drug Reactions and their Impact on Quality of Life in Patients on Antipsychotic Therapy at a Tertiary Care Center in Delhi. Indian J Psychol Med. 2017;39(3):293–8. [CrossRef] [PubMed] [Google Scholar]
- Fathelrahman AI, Mohamed Izham Mohamed Ibrahim, Wertheimer AI, editors. Pharmacy practice in developing countries: achievements and challenges. Amsterdam: Elsevier/AP, Academic Press is an imprint of Elsevier; 2016. 475 p. [Google Scholar]
- Knox K, Kelly F, Mey A, Hattingh L, Fowler JL, Wheeler AJ. Australian mental health consumers’ and carers’ experiences of community pharmacy service. Health Expect Int J Public Particip Health Care Health Policy. 2015 Dec;18(6):2107–20. [Google Scholar]
- Jebara T, Cunningham S, MacLure K, Awaisu A, Pallivalapila A, Al Hail M, et al. Healthrelated stakeholders’ perceptions of clinical pharmacy services in Qatar. Int J Clin Pharm. 2021;43(1):107–17. [CrossRef] [PubMed] [Google Scholar]
- Hindi AMK, Schafheutle EI, Jacobs S. Patient and public perspectives of community pharmacies in the United Kingdom: A systematic review. Health Expect Int J Public Particip Health Care Health Policy. 2018 Apr;21(2):409–28. [Google Scholar]
- Jebara T, Cunningham S, MacLure K, Awaisu A, Pallivalapila A, Stewart D. Stakeholders’ views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol. 2018 Sep;84(9):1883–905. [CrossRef] [PubMed] [Google Scholar]
- Abduelkarem AR. Extending the Role of Pharmacists in Patient Care: Are Pharmacists in Developing Nations Ready to Change? Pharmacol Amp Pharm. 2014;05(09):865–75. [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.